# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 6367
- **Admission ID**: 167273
- **Row ID**: 9774
- **Profile Type**: FULL

## Demographics

- **Age**: 26
- **Sex**: F
- **Date of Birth**: 2127-03-28
- **Ethnicity**: ASIAN
- **Marital Status**: SINGLE
- **Religion**: BUDDHIST
- **Insurance**: Private
- **Admission Type**: ELECTIVE
- **Admission Date**: 2153-09-19 08:00:00
- **Discharge Date**: 2153-09-22 14:39:00

## Symptoms

- **polyuria** | onset: 2152-7-6
- **polydipsia** | onset: 2152-7-6
- **significant weight gain**
- **galactorrhea**
- **cessation of menses**

## Medical History

Diabetes insipidus on DDAVP.

## Current Medications

- **Vitamin D** | dosage: 50,000 units once a month | frequency: once a month
- **DDAVP** | dosage: Nasal 10 mEq b.i.d. | frequency: twice daily | purpose: Treatment of diabetes insipidus
- **DDAVP nasal spray** | frequency: twice a day | purpose: Management of diabetes insipidus

## Discharge Medications

- **DDAVP nasal spray** | dosage: 10 mEq | frequency: b.i.d.
- **Prednisone** | dosage: 30 mg p.o. q.d. x3 days, then 20 mg p.o. q.d. x3 days, then 10 mg p.o. q.d. x3 days, then 5 mg p.o. q.d. x3 days | frequency: as described

## Diagnoses

- **Pituitary tumor** | notes: Diagnosis confirmed by MRI and clinical findings.
- **Diabetes insipidus** | notes: Based on electrolytes and symptoms; on DDAVP.
- **Pituitary stalk lesion (infundibular mass) with interval increase in size** | notes: Diagnosis based on MRI findings and clinical course.

## Treatment Options

### Biopsy of pituitary tumor

**Details**: Planned procedure for diagnostic purposes.

### Medical management

**Treatment**: DDAVP for diabetes insipidus

**Medications**:
- DDAVP (Nasal 10 mEq b.i.d.)

### Right frontal craniotomy and resection of pituitary stalk lesion

**Details**: Biopsy and possible resection performed; patient tolerated procedure well.
**Treatment**: Surgical intervention

### Steroid therapy

**Details**: Hydrocortisone 100 mg IV every 8 hours post-operatively, transitioned to prednisone taper at discharge.
**Treatment**: Steroid replacement/taper

**Medications**:
- Hydrocortisone (100 mg intravenous)
- Prednisone (30 mg p.o. q.d. x3 days, then 20 mg p.o. q.d. x3 days, then 10 mg p.o. q.d. x3 days, then 5 mg p.o. q.d. x3 days)

### Desmopressin (DDAVP) therapy

**Details**: Continued DDAVP nasal spray twice a day for management of diabetes insipidus.
**Treatment**: Hormonal therapy

**Medications**:
- DDAVP nasal spray (10 mEq)
